N-BOC-4,4-difluoro-L-proline

We are N-BOC-4,4-difluoro-L-proline CAS:203866-15-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-BOC-4,4-difluoro-L-proline
CAS.NO:203866-15-3
Synonyms:N-t-BOC-4,4-Difluoro-L-Proline
(S)-1-(tert-Butoxycarbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid
(2S)-4,4-difluoro-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid
4,4-Difluoro-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-proline
1-(tert-Butoxycarbonyl)-4,4-difluoro-L-proline
N-(tert-Butoxycarbonyl)-4,4-difluoro-L-proline
Molecular Formula:C10H15F2NO4
Molecular Weight:251.22700
 
Physical and Chemical Properties:
Density:1.31
Melting point:120-124ºC
Boiling point:340ºC
Index of Refraction:1.474
 
Specification:
Appearance:White solid
Assay:≥97.0%
Melting point:126-128ºC
Moisture:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:N-Boc-4,4-difluoro-L-proline is a reagent used in the preparation of structure-activity relationship and pharmacokinetics of pyrrolotriazines as pan-Aurora kinase inhibitors and anti tumor agents.

N-BOC-4,4-difluoro-L-proline


Related News: In addition, a high-standard GMP workshop is under construction and is expected to be put into production within the year. As the capacity bottleneck is broken, the pharmaceutical intermediate business is expected to grow rapidly in the future, providing the company with new growth momentum.(1S,3S,5S)-2-azabicyclo[3.1.0]hexane-3-carboxamide CAS:361440-68-8 A GSK spokesman said it was not yet clear by when ViiV would be able to address the FDA’s concerns.(4-metilfenil) metil tiocianato CAS:18991-39-4 Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.477600-68-3 Myelodysplastic syndromes (MDS) are conditions that can occur when the blood-forming cells in the bone marrow become dysfunctional and thus produce an inadequate number of circulating blood cells.The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.

Related Products
Product Name
2-(2,5-Diaminophenyl)ethanol sulfate View Details
N-([1,1′-Biphenyl]-4-yl)-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine View Details
2-Fluoro-5-methylaniline View Details
Dibromomethane manufacturer 2-Isobutylthiazole manufacturer 3-Chloro-2-methylaniline manufacturer 1-bromobut-2-yne manufacturer 1-(2-Tetrahydrofuroyl)piperazine hydrobromide manufacturer